Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of David Platt
Person

David Platt

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 1
Number of Founded Organizations 2
David Platt, Ph.D., Boston Therapeutics founder and CEO.

Jobs

Edit Jobs Section
Number of Current Jobs 3
David Platt has 3 current jobs including CEO at Oxygen Therapy, CEO at Boston Therapeutics, and Founder and CEO at BioXyTran.

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
David Platt is the Chairman of Board at Oxygen Therapy.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Closed East Coast Medical Companies Logo
Closed East Coast Medical Companies
19,418
Closed United States Biotechnology Companies Logo
Closed United States Biotechnology Companies
6,490
Closed Northeastern US Medical Companies Logo
Closed Northeastern US Medical Companies
21,084
Closed Greater Boston Area Companies Logo
Closed Greater Boston Area Companies
6,209
Acquired Massachusetts Companies Logo
Acquired Massachusetts Companies
2,199
Closed Northeastern US Biotechnology Companies Logo
Closed Northeastern US Biotechnology Companies
24,629
Closed United States Medical Companies Logo
Closed United States Medical Companies
9,697
Closed Massachusetts Companies Logo
Closed Massachusetts Companies
5,865
Closed Massachusetts Biotechnology Companies Logo
Closed Massachusetts Biotechnology Companies
51,664
Closed New England Biotechnology Companies Logo
Closed New England Biotechnology Companies
40,508

Education

Edit Education Section
David Platt studied at Hebrew University of Jerusalem.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 90
News•May 5, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 9, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 5, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 15, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 11, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|